Among all patients with AOCLF, extracorporeal liver support with FPSA does not increase the probability of survival.
Further studies are needed to assess whether therapy might be beneficial in specific subsets of patients.
2012-04-06
Eng.
Gastroenterology
Department of Nephrology, University Duisburg-Essen, Essen, Germany. andreas.kribben [at] uni-due.de
Gastroenterology. 2012 Apr;142(4):782-789.e3
© Galenicom 1999-2013